Sana announced that its primary islet cell therapy, UP421, had been successfully implanted into a Type 1 diabetes patient.

But experts have highlighted serious challenges for the government, including the huge amounts of funding AI infrastructure ...

The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

Fetch.ai has announced a $10 million accelerator fund to support startups innovating in AI agents, quantum computing and ...

Fetch.ai startup accelerator offers $10M fund to support AI and tech innovation in startups with mentorship and global ...

The PM pledges to boost growth with long-term AI investment, but faces questions over the current state of the economy.

This insightful feature from YourStory tests and strengthens your business acumen! Here are 5 questions to kick off this ...

Shares of Sana Biotechnology Inc. (NASDAQ: SANA) were trading at $4.97, up $3.32, or 201%, on first results from an investigator-sponsored, first-in-human study transplanting UP-421, an allogeneic ...

Investors sell off AMD shares despite the company's pivot to life sciences AI, following a rating downgrade by HSBC that followed a six-month decline in the stock price.

Syrian Foreign Minister Asaad Hassan al-Shibani visited Qatar to meet senior officials following his appointment by Syria's ...

Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...